Evidence map›Paper›PMID 37333955›Full record

ReviewFEMS microbes2020

Issues beyond resistance: inadequate antibiotic therapy and bacterial hypervirulence.

Lee W Goneau, Johannes Delport, Luana Langlois, Susan M Poutanen, Hassan Razvi, Gregor Reid, Jeremy P Burton

Open access · goldAbstract readReview
In one paragraph

Review in FEMS microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Lee W GoneauDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Johannes DelportDepartment of Pathology, London Health Sciences Center - Victoria Hospital, 800 Commissioners Rd E, London, Ontario, Canada N6A 5W9.
Luana LangloisDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Susan M PoutanenDepartment of Laboratory Medicine and Pathobiology, University of Toronto,1 King's College Cir, Toronto, ON M5S 1A8 Ontario, Canada.
Hassan RazviLawson Health Research Institute, 268 Grosvenor St, London, Ontario, N6A 4V2 Canada.
Gregor ReidDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Jeremy P BurtonDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Western University · CAUniversity of Toronto · CALawson Health Research Institute · CAVictoria Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The administration of antibiotics while critical for treatment, can be accompanied by potentially severe complications. These include toxicities associated with the drugs themselves, the selection of resistant organisms and depletion of endogenous host microbiota. In addition, antibiotics may be associated with less well-recognized complications arising through changes in the pathogens themselves. Growing evidence suggests that organisms exposed to antibiotics can respond by altering the expression of toxins, invasins and adhesins, as well as biofilm, resistance and persistence factors. The clinical significance of these changes continues to be explored; however, it is possible that treatment with antibiotics may inadvertently precipitate a worsening of the clinical course of disease. Efforts are needed to adjust or augment antibiotic therapy to prevent the transition of pathogens to hypervirulent states. Better understanding the role of antibiotic-microbe interactions and how these can influence disease course is critical given the implications on prescription guidelines and antimicrobial stewardship policies.

Indexed as

biofilmhypervirulencepathogenesispersister cellresistancesub-inhibitory antibiotic concentrationstoxinvirulence

Identifiers

PMID37333955
PMCPMC10117437
OpenAlexW3095869439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.